Nov 7 (Reuters) - The U.S. Food & Drug Administration has approved Johnson & Johnson's (JNJ.N), opens new tab device for a type of condition which causes abnormal heart rhythm, the company said on ...

The Food and Drug Administration on Tuesday approved a new device to treat non-small cell lung cancer, Novocure’s Optune Lua, which creates electric fields that its manufacturer says disrupts ...

Optune Lua is FDA approved for use with immunotherapy or docetaxel in metastatic stage IV NSCLC post-platinum treatment. The device uses tumor treating fields to disrupt cancer cell division ...

Here are six dental softwares, devices and AI programs that have received FDA clearance, as reported by Becker's since Aug. 6: 1. Dental artificial intelligence company Relu received 501(k) FDA ...

New Delhi: NovoCure, a US-based company, recently received FDA approval for its wearable device to treat metastatic cancer using Tumor Treating Fields (TTFields) technology. This non-invasive ...

After months of uncertainty and controversy, the FDA has given approval to Sarepta's Duchenne muscular dystrophy drug – even though it hasn't yet shown any proof it can slow progress of the ...

“Receiving FDA approval to initiate this pivotal study marks a significant milestone in our efforts to bring this breakthrough hearing device to more people with severe to profound hearing loss ...

The Food and Drug Administration on Tuesday approved a new device to treat non-small cell lung cancer, Novocure’s Optune Lua, which creates electric fields that its manufacturer says disrupts ...

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.